Pulse Biosciences Reports Second Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Pulse Biosciences, Inc. (PLSE) Misses Q2 EPS by 4c
August 10, 2022 4:19 PM EDTPulse Biosciences, Inc. (NASDAQ: PLSE) reported Q2 EPS of ($0.44), $0.04 worse than the analyst estimate of ($0.40). Revenue for the quarter came in at $265 thousand versus the consensus estimate of $439.67 thousand.
For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.
... More